Christchurch healthcare firm sold to US giant

American healthcare giant McKesson has bought Christchurch-based Emendo Ltd for its CapPlan software, which helps predict patient demand.

McKesson – which is listed on the NYSE, NASDAQ and S&P 500, and is 14th on the Fortune 500 – has a turnover of about $US122 billion and employs more than 37,000 people.

It is described by Bloomberg as the largest US drug distributor, but also produces IT systems for use in the healthcare sector.

Emendo is known for its CapPlan "predictive analyitcs" service, which helps healthcare providers predict patient demand.

The system "accurately forecasts future patient activity, and identifies potential congestion or overcapacity in the care process," according to its website.

The system is made up of a combination of software and "capacity planning and advisory services."

Emendo ceo Dave Tinkler says the CapPlan programme is used in 40 hospitals globally, but the scope for growth is "spectacular" as a result of the McKesson acquisition.

"The genesis of this is that we went to the market to raise capital, and in going through that process a couple of the US 'Goliath's' had a look at us.

"They indicated they would be interested in an acquisition rather than an investment, and the one that fitted  best was McKesson."

Emendo Ltd has four directors which also all serve on its management team.

They are ceo Mr Tinkler, sales and marketing manager Nick Burns, chief financial officer Phil Holliday, and operations director Bart Visscher.

According to its website, Messrs Burns and Visscher founded the company in 2002 having both had experience in operations research in the healthcare industry.

It was originally a consulting firm specialising in operational efficiency in hospitals.

An early version of CapPlan was implemented in the 650-bed Christchurch hospital in 2005, when the co-owners of Holliday Corporation, Messrs Tinkler and Holiday, bought into the company.

According to a press release, McKesson believes CapPlan is "unique in its ability to forecast future patient activity," and sees it as a way to capitalise on $700 billion of waste in the US healthcare system.

It claims a 450-bed hospital saved $1 million in its first year of use from using the system.

Mr Tinkler says the costs to hospitals of employing CapPlan vary widely depending on the type of programme they get and the size of the hospital.

"At the high end, such as Vancouver Coastal Health in Canada which used CapPlan across six or seven hospitals, it costs in the millions of dollars.

"But a 200-bed hospital in Australia or New Zealand might cost $200,000 over a three-year period."

Mr Tinkler says all of Emendo's 30 staff would be retained in the acquisition. 

3 · Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

Post Comment

3 Comments & Questions

Commenter icon key: Subscriber Verified

Well done chaps! A great company from Christchurch doing great things for the global healthcare sector.

  • 0
  • 0

Interesting that even when our dollar is supposedly so over valued, there are still US companies that see value in our companies.
The moral being that good product offerings will still sell on the world stage, irrespective of the currency.
The same is true of our vineyards, our farms and our housing. So - about time we recognise that housing affordability is more about increasing wages (relatively speaking) through domestic productivity and efficiencies than seeking to artificially lower asset prices by artificially increasing interest rates.

  • 0
  • 0

Good on them for their achievement but would be interested to know why they would have preferred to sell their company outright rather than licence their software. A pity to lose such a gem offshore but I guess who could they sell to locally .

  • 0
  • 0

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

NZ Market Snapshot


Sym Price Change
USD 0.6952 0.0000 0.00%
AUD 0.8901 0.0000 0.00%
EUR 0.5907 0.0000 0.00%
GBP 0.5276 0.0000 0.00%
HKD 5.4294 0.0000 0.00%
JPY 78.9230 0.0000 0.00%


Commodity Price Change Time
Gold Index 1278.6 -9.430 2017-10-20T00:
Oil Brent 57.8 0.550 2017-10-20T00:
Oil Nymex 51.9 0.580 2017-10-20T00:
Silver Index 17.0 -0.177 2017-10-20T00:


Symbol Open High Last %
NZX 50 8124.1 8142.3 8124.1 0.07%
NASDAQ 6633.4 6640.0 6605.1 0.36%
DAX 13057.8 13063.6 12990.1 0.01%
DJI 23205.2 23328.8 23163.0 0.71%
FTSE 7523.0 7560.0 7523.0 0.00%
HKSE 28360.0 28519.8 28159.1 1.17%
NI225 21391.0 21489.3 21448.5 0.04%
ASX 5896.1 5924.9 5896.1 0.17%